Dr. Stela Dragomanova, Medical University of Varna, Bulgaria
Dr. Stela Dragomanova is a distinguished researcher and educator at the Medical University of Varna. She earned her master’s degree in Pharmacy from the Medical University of Sofia in 2004 and later specialized in Clinical Pharmacy. In 2020, she completed her Ph.D. in Pharmacology at the Institute of Neurobiology, Bulgarian Academy of Sciences. Dr. Dragomanova’s research centers on neuropharmacology, particularly neurodegenerative diseases. She is a member of the Bulgarian Pharmaceutical Union and serves as Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna. Dr. Dragomanova has published 30+ peer-reviewed papers, contributing significantly to pharmacology and neuroscience. She has also served as Assistant Professor from 2010 to 2021 and is currently Chief Assistant Professor in the Department of Pharmacology at the Medical University of Varna.
Professional Profile
Orcid
Summary of Suitability for the Research for Best Researcher Award
Dr. Stela Dragomanova demonstrates a strong profile as a candidate for the Research for Best Researcher Award. With a Ph.D. in Pharmacology and a focus on neuropharmacology, her research is centered around neurodegenerative diseases, a critical area of biomedical research. Her expertise in in vivo preclinical models and behavioral tests positions her as a valuable contributor to the scientific community, particularly in neuropharmacology and toxicology.Her academic career includes over a decade of teaching and research at the Medical University of Varna, Bulgaria, where she has steadily advanced from Assistant Professor to Chief Assistant Professor. Dr. Dragomanova has also made substantial contributions to the scientific literature, with 30+ publications, including articles in high-impact journals such as Antioxidants and Molecules, with topics addressing neuroprotective strategies and experimental pharmacology.
Education
Dr. Stela Dragomanova began her academic journey at the Medical University of Sofia, where she obtained her master’s degree in Pharmacy in 2004. She further specialized in Clinical Pharmacy, enhancing her expertise in pharmacological interventions. Driven by her passion for neuropharmacology, Dr. Dragomanova pursued her Ph.D. in Pharmacology at the Bulgarian Academy of Sciences’ Institute of Neurobiology, completing it in 2020. Her doctoral research provided significant insights into neurodegenerative diseases and related pharmacotherapies. With a strong foundation in experimental pharmacology and toxicology, Dr. Dragomanova is equipped with advanced skills in preclinical in vivo models and behavioral testing. Her academic qualifications, coupled with her research experience, reflect her commitment to advancing knowledge in the pharmaceutical and neuropharmacological fields.
Experience
Dr. Stela Dragomanova has been an integral part of the Medical University of Varna since 2010, starting as an Assistant Professor in the Department of Pharmacology, Toxicology, and Pharmacotherapy. She transitioned into the role of Chief Assistant Professor in 2021, where she continues to lead and mentor young scientists in neuropharmacology. In her academic career, she has overseen numerous research projects focusing on neurodegenerative disorders, particularly in exploring neuroprotective agents and pharmacological treatments. She has extensive expertise in in vivo preclinical models and behavioral testing in experimental pharmacology. Dr. Dragomanova is also deeply involved in regulatory and ethical aspects of pharmacology research, serving as the Chairlady of the Ethics Committee for the Regional Pharmaceutical Collegium in Varna and being an active member of several scientific and pharmaceutical associations.
Awards and Honors
Dr. Stela Dragomanova has been recognized for her outstanding contributions to the field of pharmacology and her dedication to healthcare and education. In 2018, she was named “Pharmacist of the Year” for the Varna region by the Regional Pharmaceutical Collegium. This prestigious award highlights her commitment to the pharmaceutical profession and the positive impact of her work in the healthcare sector. In addition to her regional recognition, Dr. Dragomanova is an esteemed member of the Bulgarian Pharmaceutical Union, which is part of the Pharmaceutical Group of the European Union (PGEU). She also holds leadership roles in several academic and professional organizations, including the Bulgarian Association of Pharmacology, Clinical Pharmacology, and Therapeutics. Her extensive experience in both research and education further solidifies her as a prominent figure in the pharmacological sciences.
Research Focus
Dr. Stela Dragomanova’s research is primarily focused on neuropharmacology, particularly in understanding the mechanisms underlying neurodegenerative diseases. Her work aims to discover potential therapeutic agents that can mitigate the progression of disorders such as Alzheimer’s and Parkinson’s disease. She has developed expertise in using in vivo preclinical models to evaluate neuroprotective compounds and conduct behavioral tests. Her research explores the role of antioxidants and polyphenols, studying their neuroprotective effects and potential applications in pharmacotherapy. Additionally, Dr. Dragomanova is interested in the therapeutic potential of lipid emulsions in treating convulsions and other toxicological conditions. Her investigations have led to a deeper understanding of the molecular and biochemical processes that drive neurodegeneration, with a strong focus on developing novel interventions for these challenging medical conditions.
Publications Top Notes
-
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
-
Trehalose: Neuroprotective Effects and Mechanisms—An Updated Review
-
Intravenous Lipid Emulsions in Anticonvulsants’ Toxicity
-
Neuropharmacological investigation of myrtenal conjugates with aminoadamantane
-
Emerging Therapeutic Potential of Polyphenols from Geranium sanguineum L. in Viral Infections, Including SARS-CoV-2